Condition
Sjögren's Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Sjögren's Disease clinical trials that are recruiting, at sites in 21 countries (most in Australia (4), China (3), Canada (2)). By phase: Phase 1 (2), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 21Countries
Newest Sjögren's Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Telitacicept for primary Sjögren’s with interstitial lung disease | — | Beijing | Recruiting | Sep 28, 2026 |
| DDY391 in Sjögren's disease: see if it works and is safe | Phase 2 | Avondale, Arizona and 30 other locations | Recruiting | Jul 30, 2026 |
| Test of HBM7020 in healthy adults and adults with autoimmune diseases | Phase 1 | Brisbane, Queensland | Recruiting | Jun 16, 2026 |
| Ianalumab vs placebo in adults with Sjögren's disease and high symptom burden | Phase 3 | Peoria, Arizona and 71 other locations | Recruiting | Jun 2, 2026 |
| Phase 1 safety test of XmAb657 in healthy adults and people with myositis, scleroderma, or Sjögren's | Phase 1 | Melbourne | Recruiting | Dec 16, 2025 |
All recruiting trials (5)
-
Telitacicept for primary Sjögren’s with interstitial lung disease
This study tests whether Telitacicept helps people with primary Sjögren’s syndrome and interstitial lung disease compared with standard immunosuppressants.
-
DDY391 in Sjögren's disease: see if it works and is safe
This study tests whether DDY391 is effective and safe for people with Sjögren's disease over up to 52 weeks.
-
Test of HBM7020 in healthy adults and adults with autoimmune diseases
This first-in-human study tests whether HBM7020 is safe and how it acts in the body for people with autoimmune diseases like RA, SLE, Sjögren's, and SSc compared with healthy volunteers.
-
Ianalumab vs placebo in adults with Sjögren's disease and high symptom burden
A 52-week study will test whether monthly 300 mg ianalumab injections help adults with Sjögren's disease who have high symptom burden.
-
Phase 1 safety test of XmAb657 in healthy adults and people with myositis, scleroderma, or Sjögren's
This study will test whether subcutaneous injections of XmAb657 are safe and well tolerated in healthy adults and people with autoimmune diseases such as idiopathic inflammatory myopathies, systemic sclerosis, or primary Sjögren's syndrome.
Related topics
Quick answers
How many Sjögren's Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in Australia (4 trials), China (3 trials), Canada (2 trials), Colombia (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.